Concizumab Safe and Effective in Patients With Hemophilia With Inhibitors

Summary: A new daily shot called concizumab is proving to be a game-changer for people with hemophilia A or B who have "inhibitors" (which are antibodies that stop standard treatments from working). In a recent study lasting over a year, patients taking this medicine had far fewer bleeding episodes. Even better, nearly 92% of painful, damaged joints healed up after treatment. The medicine was also found to be very safe, with no new safety issues or dangerous blood clots reported.

Source: rssapp-hematologyadvisor-com URL: hematologyadvisor.com/news/hemophilia-inhibitors-concizumab-safe-effective-treatment-risk/ (opens in new tab)